CELLULAR NANOPARTICLE (CNP) Trademark
Trademark Overview
On Thursday, May 26, 2022, a trademark application was filed for CELLULAR NANOPARTICLE (CNP) with the United States Patent and Trademark Office. The USPTO has given the CELLULAR NANOPARTICLE (CNP) trademark a serial number of 97430828. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, July 17, 2025. This trademark is owned by Arytha Biosciences, LLC. The CELLULAR NANOPARTICLE (CNP) trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as drug delivery vehicles for targeted delivery of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as therapeutic pharmaceuticals for the treatment of infectious disease, cancer, inflammatory disease, cardiovascular disease, and autoimmune disease
General Information
| Serial Number | 97430828 |
| Word Mark | CELLULAR NANOPARTICLE (CNP) |
| Filing Date | Thursday, May 26, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, July 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 13, 2023 |
Trademark Statements
| NOT AVAILABLE | "CELLULAR NANOPARTICLE" |
| Goods and Services | Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as drug delivery vehicles for targeted delivery of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as therapeutic pharmaceuticals for the treatment of infectious disease, cancer, inflammatory disease, cardiovascular disease, and autoimmune disease |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Arytha Biosciences, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Diego, CA 92121
US |
| Party Name | Arytha Biosciences, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Diego, CA 92121
US |
Trademark Events
| Event Date | Event Description |
| Monday, May 30, 2022 | NEW APPLICATION ENTERED |
| Thursday, June 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 14, 2023 | ASSIGNED TO EXAMINER |
| Monday, March 20, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, March 20, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, March 20, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, May 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, May 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 9, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 24, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 13, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 13, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 8, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 11, 2024 | SOU EXTENSION 1 FILED |
| Thursday, January 11, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, January 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 16, 2024 | SOU EXTENSION 2 FILED |
| Thursday, May 16, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 27, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 27, 2025 | SOU EXTENSION 3 FILED |
| Tuesday, January 28, 2025 | SOU EXTENSION 3 GRANTED |
| Tuesday, March 4, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 17, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 17, 2025 | SOU EXTENSION 4 FILED |
| Thursday, July 17, 2025 | SOU EXTENSION 4 GRANTED |
| Friday, July 18, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 30, 2026 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 18, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
